Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening
NCT ID: NCT00921544
Last Updated: 2009-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2008-08-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Oral Sucrose and Topical Anesthetics to Reduce Pain During Eye Examination for Retinopathy of Prematurity
NCT01811979
Use of Sucrose to Relieve Pain During Eye Exams in Infants
NCT00161694
Analgesic Efficacy of Different Doses of Sucrose During Blood Sampling in Preterm Infants
NCT02859376
Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%
NCT01742520
Pain Response During Examination for Retinopathy of Prematurity
NCT00648687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Sucrose
Oral sucrose administered 2 mins prior to eye exam
Sucrose
0.2 ml sucrose 24% given by mouth using a syringe and pacifier
Sterile water
0.2 mls of sterile water
Sterile water
Sterile water administered 2 mins prior to eye exam
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sucrose
0.2 ml sucrose 24% given by mouth using a syringe and pacifier
Sterile water
Sterile water administered 2 mins prior to eye exam
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \< 32 weeks
Exclusion Criteria
* Infants where consent to participate was not obtained
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coombe Women and Infants University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Coombe Women and Infants University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eugene Dempsey, MD, FRCPI
Role: STUDY_DIRECTOR
Coombe Women and Infants University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coombe Women and Infants University Maternity Hospital
Dublin, Dublin, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Coombesucrose
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.